Mirum Pharmaceuticals, Inc.
Overview
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies for debilitating liver diseases. The company targets rare liver diseases with significant unmet needs, leveraging its expertise to advance its pipeline and bring new treatments to market.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Mirum Pharmaceuticals, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Albireo Pharma, Inc.
United States
Digestive Health Institute
United States
Salix Pharmaceuticals, Inc.
United States
Takeda Pharmaceuticals America, Inc.
United States
Takeda Pharmaceuticals Company Limited
United States
Takeda Pharmaceuticals North America, Inc.
United States
Takeda Pharmaceuticals U.S.A., Inc.
United States
Dr. Falk Pharma GmbH
Germany
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.